The industry's profit growth sharply outpaced the rest of Corporate America the past 10 years, a trend unlikely to change any time soon even if Congress passes the overhaul now on Capitol Hill, experts say.

It’s understandable to feel a bit sick when you’re trying to decide whether to throw your money into a hospital stock. But many analysts believe that despite the current turmoil around health-care reform hospital company stocks will continue to rise as more Americans win access to insurance coverage through the legislation.But gains will be modest analysts say so don’t tuck all your money into one hospital bed.This past weekend the House passed health-care reform bill HR 3962 by a narrow margin. The bill which faces a tough reception from the Senate and promises to bring “affordable quality health care ...

The weekend passage of major health-care reform with a public option by the House fails to dent stocks throughout the sector Monday, as even insurers show an ability to ride the broader market's bullish momentum to gains.

The healthcare reform bill may actually boost healthcare provider and generic drugmaker stocks even further.

The top performing mid cap stocks in September 2009 contained a few surprises from sectors that had been left for dead by investors.

Webinar Will Reveal How to Calculate Ultimate Measurement of Revenue Cycle Success

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Ridgewater Equity (RWE).

Additions Include Chairman Michael Solomon; Directors Alan Bailey, Donald Kurz, Michael O'Connor and Chuck Timpe; President Carl Freer; and COO Derek Norton